Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial

Michiel Coppens, Steven W. Pipe, Wolfgang Miesbach, Jan Astermark, Michael Recht, Paul van der Valk, Bruce M. Ewenstein, Karen Pinachyan, Nicholas Galante, Sandra Le Quellec,

The Lancet Haematology · 2024 · 60 citations · 20 references

DOIFull text

Open access

Concepts

References

20